Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity?

Research output: Contribution to journalJournal articleResearchpeer-review

139 Downloads (Pure)


Calcineurin inhibitors have markedly reduced acute rejection rates in renal transplantation, thus significantly improved short-term outcome. The beneficial effects are, however, tampered by acute and chronic nephrotoxicity leading to interstitial fibrosis and tubular atrophy, which impairs long-term allograft survival. The mineralocorticoid hormone aldosterone induces fibrosis in numerous organs, including the kidney. Evidence from animal models suggests a beneficial effect of aldosterone antagonism in reducing calcineurin inhibitor-induced nephrotoxicity. This review summarizes current evidence of mineralocorticoid receptor antagonism in animal models of calcineurin inhibitor-induced nephrotoxicity and the results from studies of mineralocorticoid antagonism in renal transplant patients.

Original languageEnglish
Article number210
JournalFrontiers in Medicine
Issue numberNOV
Number of pages8
Publication statusPublished - 1. Jan 2017


  • Aldosterone
  • Cyclosporine A
  • Fibrosis
  • IF/TA
  • Mineralocorticoid
  • Tacrolimus


Dive into the research topics of 'Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity?'. Together they form a unique fingerprint.

Cite this